［1］ BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2024,74(3):229-263.
［2］ DONG J,ZENG M,JI N,et al.Impact of anesthesia on long-term outcomes in patients with supratentorial high-grade glioma undergoing tumor resection:a retrospective cohort study［J］.Journal of Neurosurgical Anesthesiology,2020,32(3):227-233.
［3］ GLUTH L,OCHSENFARTH C,PHAM PNV,et al.Influence of the anesthetic technique on circulating extracellular vesicles in bladder cancer patients undergoing radical cystectomy:A prospective,randomized trial［J］.Cells,2023,12(20):2503.
［4］ HAN XC,ZHANG YJ,DONG X,et al.Sevoflurane modulates the cancer stem cell-like properties and mitochondrial membrane potential of glioma via Ca2+-dependent CaMKII/JNK cascade［J］.Life Sciences,2020,253:117675.
［5］ ENLUND M,BERGLUND A,AHLSTRAND R,et al.Survival after primary breast cancer surgery following propofol or sevoflurane general anesthesia-A retrospective,multicenter,database analysis of 6305 Swedish patients［J］.Acta Anaesthesiologica Scandinavica,2020,64(8):1048-1054.
［6］ CIECHANOWICZ S,ZHAO H,CHEN Q,et al.Differential effects of sevoflurane on the metastatic potential and chemosensitivity of non-small-cell lung adenocarcinoma and renal cell carcinoma in vitro［J］.British Journal of Anaesthesia,2018,120(2):368-375.
［7］ ZHANG W,SHENG B,CHEN S,et al.Sevoflurane enhances proliferation,metastatic potential of cervical cancer cells via the histone deacetylase 6 modulation in vitro［J］.Anesthesiology,2020,132(6):1469-1481.
［8］ LAI RC,SHAN WR,ZHOU D,et al.Sevoflurane promotes migration,invasion,and colony-forming ability of human glioblastoma cells possibly via increasing the expression of cell surface protein 44［J］.Acta Pharmacologica Sinica,2019,40(11):1424-1435.
［9］ LI R,HUANG Y,LIN J.Distinct effects of general anesthetics on lung metastasis mediated by IL-6/JAK/STAT3 pathway in mouse models［J］.Nature Communications,2020,11(1):642.
［10］ HU C,WANG B,LIU Z,et al.Sevoflurane but not propofol enhances ovarian cancer cell biology through regulating cellular metabolic and signaling mechanisms［J］.Cell Biology and Toxicology,2023,39(4):1395-1411.
［11］ YU F,BAI T.Sevoflurane activates the IL-6/HO-1 pathway to promote macrophage M2 polarization and prostate cancer lung metastasis［J］.International Immunopharmacology,2022,113(Pt A):109380.
［12］ TIRON CE,PATRASCANU E,POSTU PA,et al.Sevoflurane modulates AKT isoforms in triple negative breast cancer cells.An experimental study［J］.Current Issues in Molecular Biology,2021,43(1):264-275.
［13］ GAO C,HE XF,XU QR,et al.Sevoflurane downregulates insulin-like growth factor-1 to inhibit cell proliferation,invasion and trigger apoptosis in glioma through the PI3K/AKT signaling pathway［J］.Anti-Cancer Drugs,2019,30(7):e0744.
［14］ DING J,ZHANG L,ZENG S,et al.Clinically relevant concentration of sevoflurane suppresses cervical cancer growth and migration through targeting multiple oncogenic pathways［J］.Biochemical and Biophysical Research Communications,2019,514(4):1179-1184.
［15］ KANG K,WANG Y.Sevoflurane inhibits proliferation and invasion of human ovarian cancer cells by regulating JNK and p38 MAPK signaling pathway［J］.Drug Design,Development and Therapy,2019,13:4451-4460.
［16］ YANG Y,HU R,YAN J,et al.Sevoflurane inhibits the malignant potential of head and neck squamous cell carcinoma via activating the hypoxia-inducible factor-1α signaling pathway in vitro［J］.International Journal of Molecular Medicine,2018,41(2):995-1002.
［17］ QUAN Y,LI S,WANG Y,et al.Propofol and sevoflurane alleviate malignant biological behavior and cisplatin resistance of Xuanwei lung adenocarcinoma by modulating the Wnt/β-catenin pathway and PI3K/AKT pathway［J］.Anti-Cancer Agents in Medicinal Chemistry,2022,22(11):2098-2108.
［18］ YANG X,ZHENG YT,RONG W.Sevoflurane induces apoptosis and inhibits the growth and motility of colon cancer in vitro and in vivo via inactivating Ras/Raf/MEK/ERK signaling［J］.Life Sciences,2019,239:116916.
［19］ ISHIKAWA M,IWASAKI M,ZHAO H,et al.Sevoflurane and desflurane exposure enhanced cell proliferation and migration in ovarian cancer cells via miR-210 and miR-138 downregulation［J］.International Journal of Molecular Sciences,2021,22(4):1826.
［20］ SHI QY,ZHANG SJ,LIU L,et al.Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro［J］.British Journal of Anaesthesia,2015,114(5):825-830.
［21］ NISHIWADA T,KAWARAGUCHI Y,UEMURA K,et al.Effect of sevoflurane on human hepatocellular carcinoma HepG2 cells under conditions of high glucose and insulin［J］.Journal of Anesthesia,2015,29(5):805-808.
［22］ LI Y,ZENG QG,QIU JL,et al.Sevoflurane inhibits the progression of PTC by downregulating miR-155［J］.European Review for Medical and Pharmacological Sciences,2019,23(15):6579-6587.
［23］ WU T,SUN L,WANG C,et al.Sevoflurane suppresses the migration,invasion,and epithelial-mesenchymal transition of breast cancer cells through the miR-139-5p/ARF6 axis［J］.The Journal of Surgical Research,2021,258:314-323.
［24］ GAO C,SHEN J,MENG ZX,et al.Sevoflurane inhibits glioma cells proliferation and metastasis through miRNA-124-3p/ROCK1 axis［J］.Pathology Oncology Research,2020,26(2):947-954.
［25］ CHEN M,ZHOU L,LIAO Z,et al.Sevoflurane inhibited osteosarcoma cell proliferation and invasion via targeting miR-203/WNT2B/Wnt/β-catenin axis［J］.Cancer Management and Research,2019,11:9505-9515.
［26］ SONG G,TIAN L,CHENG Y,et al.Antitumor activity of sevoflurane in HCC cell line is mediated by miR-29a-induced suppression of Dnmt3a［J］.Journal of Cellular Biochemistry,2019,120(10):18152-18161.
［27］ FAN L,WU Y,WANG J,et al.Sevoflurane inhibits the migration and invasion of colorectal cancer cells through regulating ERK/MMP-9 pathway by up-regulating miR-203［J］.European Journal of Pharmacology,2019,850:43-52.
［28］ SUN SQ,REN LJ,LIU J,et al.Sevoflurane inhibits migration and invasion of colorectal cancer cells by regulating microRNA-34a/ADAM10 axis［J］.Neoplasma,2019,66(6):887-895.
［29］ CHEN H,ZHU XM,LUO ZL,et al.Sevoflurane induction alleviates the progression of gastric cancer by upregulating the miR-34a/TGIF2 axis［J］.European Review for Medical and Pharmacological Sciences,2020,24(22):11883-11890.
［30］ XIONG K,WU Z.Sevoflurane confers protection against the malignant phenotypes of lung cancer cells via the microRNA-153-3p/HIF1α/KDM2B axis［J/OL］.Biochemical Genetics (2023-12-21)［2024-05-26］.https://doi.org/10.1007/s10528-023-10607-2.
［31］ SONG W,MIAO L,ZHANG K,et al.Sevoflurane suppresses colorectal cancer malignancy by modulating β-catenin ubiquitination degradation via circSKA3［J］.Cellular Signalling,2024,114:110987.
［32］ HE J,ZHAO H,LIU X,et al.Sevoflurane suppresses cell viability and invasion and promotes cell apoptosis in colon cancer by modulating exosome-mediated circ-HMGCS1 via the miR-34a-5p/SGPP1 axis［J］.Oncology Reports,2020,44(6):2429-2442.
［33］ ZENG X,ZHENG Q,WANG L,et al.Sevoflurane suppresses the malignant progression of breast cancer via the hsa_circ_0000129/miR-578/EPSTI1 axis［J］.Thoracic Cancer,2023,14(26):2665-2677.
［34］ GAO Y,MA H,HOU D.Sevoflurane represses proliferation and migration of glioma cells by regulating the ANRIL/let-7b-5p axis［J］.Cancer Biotherapy & Radiopharmaceuticals,2024,39(2):117-124.
［35］ KIM HJ,JEON S,LEE HJ,et al.Effects of sevoflurane on metalloproteinase and natural killer group 2,member D (NKG2D) ligand expression and natural killer cell-mediated cytotoxicity in breast cancer:an in vitro study［J］.Korean Journal of Anesthesiology,2023,76(6):627-639.
［36］ JEON S,KIM HK,KWON JY,et al.Role of sevoflurane on natural killer group 2,member D-mediated immune response in non-small-cell lung cancer:An in vitro study［J］.Medical Science Monitor,2020,26:e926395.
［37］ LIU S,GU X,ZHU L,et al.Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer［J］.Medicine,2016,95(49):e5479.
［38］ GAO C,XU YJ,QI L,et al.CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis［J］.Cell Biology and Toxicology,2022,38(5):825-845.
［39］ SZTWIERTNIA I,SCHENZ J,BOMANS K,et al.Sevoflurane depletes macrophages from the melanoma microenvironment［J］.PLoS One,2020,15(5):e0233789.
［40］ OH CS,LEE J,YOON TG,et al.Effect of equipotent doses of propofol versus sevoflurane anesthesia on regulatory T cells after breast cancer surgery［J］.Anesthesiology,2018,129(5):921-931.
［41］ OH CS,PARK HJ,PIAO L,et al.Expression profiles of immune cells after propofol or sevoflurane anesthesia for colorectal cancer surgery:A prospective double-blind randomized trial［J］.Anesthesiology,2022,136(3):448-458.
［42］ GAO Z,XU J,COBURN M,et al.Postoperative long-term outcomes and independent risk factors of non-small-cell lung cancer patients with propofol versus sevoflurane anesthesia:A retrospective cohort study［J］.Frontiers in Pharmacology,2022,13:945868.
［43］ SHIONO S,SHIBATA SC,KABATA D,et al.Comparison of 1-year recurrence-free survival between sevoflurane and propofol use for general anesthesia management in primary breast cancer surgery［J］.Journal of Anesthesia,2020,34(5):694-701.
［44］ KAGAWA T,KURAHASHI K,SEKI T,et al.The association between intraoperative anesthesia methods used during gastric cancer surgery and long-term mortality:A retrospective observational study using a Japanese claims database［J］.Journal of Anesthesia,2024,38(1):92-97.
［45］ HOVAGUIMIAN F,BRAUN J,Z' GRAGGEN BR,et al.Anesthesia and circulating tumor cells in primary breast cancer patients:a randomized controlled trial［J］.Anesthesiology,2020,133(3):548-558.
［46］ YAN T,ZHANG GH,WANG BN,et al.Effects of propofol/remifentanil-based total intravenous anesthesia versus sevoflurane-based inhalational anesthesia on the release of VEGF-C and TGF-β and prognosis after breast cancer surgery:a prospective,randomized and controlled study［J］.BMC Anesthesiology,2018,18(1):131.
［47］ YAN T,ZHANG GH,CHENG YZ,et al.Effects of anesthetic technique and surgery on myeloid-derived suppressor cells and prognosis in women who underwent breast cancer surgery:a prospective study［J］.Cancer Management and Research,2019,11:5513-5522.
［48］ ENLUND M,BERGLUND A,ENLUND A,et al.Impact of general anaesthesia on breast cancer survival:a 5-year follow up of a pragmatic,randomised,controlled trial,the CAN-study,comparing propofol and sevoflurane［J］.EClinicalMedicine,2023,60:102037.
［49］ SESSLER DI,PEI L,HUANG Y,et al.Recurrence of breast cancer after regional or general anaesthesia:a randomised controlled trial［J］.Lancet (London,England),2019,394(10211):1807-1815.
［50］ CAO SJ,ZHANG Y,ZHANG YX,et al.Long-term survival in older patients given propofol or sevoflurane anaesthesia for major cancer surgery:follow-up of a multicentre randomised trial［J］.British Journal of Anaesthesia,2023,131(2):266-275.
［51］ TAKEYAMA E,MIYO M,MATSUMOTO H,et al.Long-term survival differences between sevoflurane and propofol use in general anesthesia for gynecologic cancer surgery［J］.Journal of Anesthesia,2021,35(4):495-504.
［52］ ZHENG X,WANG Y,DONG L,et al.Effects of propofol-based total intravenous anesthesia on gastric cancer:a retrospective study［J］.OncoTargets and Therapy,2018,11:1141-1148.
［53］ GUERRERO ORRIACH JL,RAIGON PONFERRADA A,MALO MANSO A,et al.Anesthesia in combination with propofol increases disease-free survival in bladder cancer patients who undergo radical tumor cystectomy as compared to inhalational anesthetics and opiate-based analgesia［J］.Oncology,2020,98(3):161-167.
［54］ YANG S,HU X,HAN Y.Effect of thoracic paraspinal block-propofol intravenous general anesthesia on VEGF and TGF-β in patients receiving radical resection of lung cancer［J］.Medicine,2019,98(47):e18088.